DPP4 and metabolic disease: Multiple studies have shown that long-term DPP-4 inhibition effectively ameliorates metabolic disorders and preserves pancreatic functions in diabetic animal models (Fan et al., 2022; Thomas et al., 2009; Furuta et al., 2010).